Related Experiment Video
Updated: Jan 25, 2026

Protocols for Robust Herbicide Resistance Testing in Different Weed Species
Published on: July 2, 2015
[Status quo and countermeasure of clopidogrel resistance predicted by gene testing]
1Department of Neurology, the Affiliated Hospital of Qingdao University, Shandong 266071, China.
Insights
Genetic testing can identify clopidogrel resistance, a condition where patients don't respond well to antiplatelet therapy. This helps personalize treatment to prevent cardiovascular events.
Area of Science:
- Pharmacogenomics
- Cardiovascular Medicine
- Clinical Pharmacy
Background:
- Clopidogrel is a vital antiplatelet medication.
- Individual responses to clopidogrel vary, leading to clopidogrel resistance in some patients.
- This resistance can result in recurrent cardio- and cerebrovascular thrombosis.
Purpose of the Study:
- To review the current understanding of clopidogrel resistance.
- To explore the role of genetic testing in predicting and managing clopidogrel resistance.
- To discuss strategies for addressing clopidogrel resistance based on genetic factors.
Main Methods:
- Review of existing literature on clopidogrel resistance and genetic polymorphisms.
- Analysis of the application of genetic testing in antiplatelet therapy.
- Evaluation of methods for predicting clopidogrel resistance through genetic markers.
Main Results:
- Genetic polymorphism is a primary cause of individual differences in clopidogrel response.
- Genetic testing enables the assessment of antiplatelet therapy efficacy.
- Testing can guide therapeutic adjustments and predict thromboembolic event risk.
Conclusions:
- Genetic testing is crucial for identifying patients at risk of clopidogrel resistance.
- Personalized antiplatelet therapy based on genetic profiles can improve patient outcomes.
- Further research and clinical application of genetic testing are needed to combat clopidogrel resistance.
Abstract:
Clopidogrel is the cornerstone of antiplatelet therapy, but there are ethnic and individual differences in the suppression of platelets. Some patients regularly taking drugs still cannot prevent the recurrence of cardio- and cerebrovascular thrombosis, thereby manifest low drug reactivity, i.e., clopidogrel resistance. Genetic polymorphism is the main reason for individual difference. Genetic testing has been used for evaluating the efficacy of antiplatelet therapy, adjusting therapeutic plan, and predicting the risk of cardio- and cerebrovascular thromboembolic events by determining the genetic polymorphisms related with antiplatelet drugs. This article provides a review for the status quo and countermeasure of clopidogrel resistance predicted by gene testing.
More Related Videos
Related Concept Videos
Predicting Molecular Geometry
Marcia's Theory of Identity Status
Resistivity
Resistance
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Gene Flow

